Circulating mRNA for the PLAC1 Gene as a Second Trimester Marker (14-18 Weeks' Gestation) in the Screening for Late Preeclampsia

Publisher： Karger

E-ISSN： 1421-9964|36|3|196-201

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.36, Iss.3, 2014-08, pp. : 196-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid Clearance of mRNA for PLAC1 Gene in Maternal Blood after Delivery

By  

Fetal Diagnosis and Therapy, Vol. 20, Iss. 1, 2004-12 ,pp. : 27-30

Karger

Access to resources Recommend Favorite

Late Second-Trimester Nonstress Test Characteristics in Preterm Delivery before 32 Weeks of Gestation

By  

Gynecologic and Obstetric Investigation, Vol. 51, Iss. 1, 2001-01 ,pp. : 32-35

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-05 ,pp. : 240-248

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor Isoforms 1 and 2 at 11-13, 20-24 and 30-34 Weeks' Gestation in Late-Onset Pre-Eclampsia and Small for Gestational Age Neonates

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-03 ,pp. : 249-257

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 1, 2014-05 ,pp. : 9-17

Karger

Access to resources Recommend Favorite